A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Charite Universitaetsklinikum Berlin - Campus Benjamin Franklin /ID# 214197, Berlin

AP-HM - Hopital de la Timone /ID# 215657, Marseille

Roswell Park Comprehensive Cancer Center /ID# 215882, Buffalo

Hospital Universitario 12 de Octubre /ID# 214198, Madrid

Hospital Universitario HM Sanchinarro /ID# 214110, Madrid

Hospital Universitario de Fuenlabrada /ID# 214263, Fuenlabrada

Hospital Universitario Virgen de la Victoria /ID# 214109, Málaga

Hopital Saint-Andre /ID# 215702, Bordeaux

Hospital Clinico Universitario de Valencia /ID# 221401, Valencia

Barbara Ann Karmanos Cancer In /ID# 214050, Detroit

Nebraska Methodist Hospital /ID# 215786, Omaha

Institut Curie /ID# 215653, Paris

MD Anderson Cancer Center /ID# 214041, Houston

Universitaetsklinikum Erlangen /ID# 214196, Erlangen

Gastroenterology Institute, Division of Medicine /ID# 215862, Jerusalem

Rambam Health Care Campus /ID# 215231, Haifa

The Chaim Sheba Medical Center /ID# 215229, Ramat Gan

The University of Chicago Medical Center /ID# 217196, Chicago

Norton Cancer Institute /ID# 216179, Louisville

Atlantic Health System /ID# 216159, Morristown

Vanderbilt Ingram Cancer Center /ID# 214040, Nashville

Centre Antoine Lacassagne - Nice /ID# 215706, Nice

Universitaetsklinikum Leipzig /ID# 214200, Leipzig

Antoni van Leeuwenhoek /ID# 215291, Amsterdam

Instituto Catalan de Oncologia (ICO) L'Hospitalet /ID# 221402, L'Hospitalet de Llobregat

Hospital Clinic de Barcelona /ID# 214264, Barcelona